AVANOS MEDICAL INC (AVNS) Stock Income Statement
NYSE:AVNS - US05350V1061 - Common Stock
11.94 USD
+0.07 (+0.59%)
11.94 USD
0 (0%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 692.50M | 687.80M | 673.30M | 820.00M | 744.60M | |||
| Cost Of Goods | 321.00M | 307.00M | 294.00M | 370.00M | 380.30M | |||
| Gross Profit | 372.80M | 381.30M | 379.70M | 450.00M | 364.30M | |||
| Operating Expenses | 326.40M | 336.00M | 371.70M | 374.00M | 347.60M | |||
| Research and Development | 24.10M | 26.20M | 27.20M | 30.60M | 32.30M | |||
| Selling, General, and Administrative Expenses | 313.00M | 314.00M | 332.00M | 339.90M | 300.30M | |||
| Operating Income | 43.60M | 45.00M | 7.50M | 76.00M | 16.70M | |||
| Interest Income/Expense | -6.50M | -7.10M | -12.10M | -7.70M | -3.10M | |||
| Non Recurring Items | N/A | -441.00M | -3.30M | -3.10M | -7.80M | |||
| Income Before Taxes | -477.80M | -403.00M | -7.90M | 65.20M | 5.80M | |||
| Income Tax | -16.40M | -17.00M | 2.00M | 14.70M | 600.00K | |||
| Net Income | -463.10M | -392.00M | -62.00M | 50.50M | 5.20M | |||
| EBITDA | 86.60M | 91.00M | 53.50M | 123.70M | 55.00M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -10.06 | -8.52 | -1.31 | 1.07 | 0.11 | |||
| Non GAAP EPS | 1.21 | 1.26 | 1.38 | 1.65 | 1.15 | |||
| Statistics | ||||||||
| Gross Profit Margin | 53.83% | 55.44% | 56.39% | 54.88% | 48.93% | |||
| Profit Margin | -66.87% | -56.99% | -9.21% | 6.16% | 0.70% | |||
| Operating Profit Margin | 6.30% | 6.54% | 1.11% | 9.27% | 2.24% | |||
All data in USD